In an 89-year-old patient with painful rotator cuff degeneration, how is the injection site for a corticosteroid (cortisone) shot determined?

Injection Site Determination for Cortisone in Rotator Cuff Degeneration

The cortisone injection should be placed in the subacromial bursa, ideally using ultrasound guidance to ensure accurate delivery to this specific anatomical space. 1

Anatomical Target: The Subacromial Bursa

The subacromial bursa is the primary injection site for rotator cuff pathology because:

• This is where the inflammatory process occurs in rotator cuff degeneration, impingement, and tendinopathy
• The bursa lies between the acromion and the rotator cuff tendons, making it the ideal location for corticosteroid delivery to reduce pain and inflammation
• Multiple studies confirm subacromial injection as the standard approach 2, 3, 4, 5

Ultrasound Guidance vs. Landmark-Based Technique

Use ultrasound guidance when available, though the evidence shows both approaches can be effective:

• Ultrasound guidance ensures accurate placement in the subacromial space
• Interestingly, one high-quality RCT found that ultrasound-guided subacromial injection was not significantly superior to systemic (intramuscular gluteal) injection for overall outcomes 2, suggesting that even systemic corticosteroid delivery can provide benefit
• However, direct subacromial placement remains the standard of care and logical approach for targeting local pathology 3, 4, 5

Specific Injection Technique

The injection typically consists of:

• 1 mL of corticosteroid (e.g., 40 mg triamcinolone acetonide or equivalent) 4, 5
• 1 mL of local anesthetic (e.g., 2% lidocaine or xylocaine) 3
• Combined in the same syringe for subacromial bursa injection

Critical Considerations for Your 89-Year-Old Patient

Age-Related Factors

• Strong evidence indicates older age is associated with poorer outcomes after rotator cuff repair 1, making conservative management with injections particularly appropriate
• Surgery is generally not recommended for this age group given the high failure rates

Timing and Safety Concerns

• Limit to a single injection initially - moderate evidence supports single injection for short-term pain and function improvement 1
• Studies show no additional benefit from repeat injections at 21-day intervals 5
• Critical warning: If surgery is ever considered, injections within 4 weeks prior increase infection risk 6
• However, at age 89 with degenerative changes, surgery is unlikely to be pursued

Expected Outcomes

• Pain relief typically occurs within days to 1 week 7, 4, 5
• Maximum benefit at 1-3 months 4, 5
• Effects may last 3-6 months 3, 4
• Approximately 88-91% satisfaction rate at one year 3

Common Pitfalls to Avoid

1. Do not inject into the tendon itself - this increases risk of tendon degeneration and rupture
2. Do not use multiple injections routinely - no evidence of added benefit and increases complication risk 5
3. Do not inject if infection is suspected - corticosteroids mask infection signs 8
4. Monitor for diabetes - elderly patients have increased risk of hyperglycemia 8
5. Consider osteoporosis risk - use lowest effective dose in this elderly patient 8

Alternative Injection Sites (Not Recommended)

• Intra-articular (glenohumeral joint) injection: Some studies used this approach 4, 5, but subacromial remains the preferred target for rotator cuff pathology
• Intramuscular/systemic injection: While one study showed similar outcomes 2, this is not standard practice for localized rotator cuff disease

Clinical Decision Algorithm

1. Confirm diagnosis through physical examination (positive impingement signs, painful arc, weakness)
2. Identify the subacromial space using either ultrasound or anatomical landmarks
3. Inject 1 mL corticosteroid + 1 mL local anesthetic into the subacromial bursa
4. Combine with rehabilitation exercises - injection alone is inferior to injection plus physical therapy 9
5. Reassess at 1-4 weeks for pain relief
6. If no improvement by 3 months, consider imaging to rule out full-thickness tear 3

The evidence strongly supports subacromial bursa injection as the anatomically correct and clinically effective site for cortisone delivery in rotator cuff degeneration. 1, 3, 4, 5